Hays Plc forecasts £45m FY25 profit

Hays Plc

Hays Plc (LON:HAS) has announced itsa pre-close year end trading update.

c.£45m pre-exceptional operating profit expected in FY25 primarily due to more challenging Perm markets

Activity levels during our fourth quarter (ending 30 June) have reduced sequentially driven primarily by broad-based weakness in Perm markets globally reflecting low levels of client and candidate confidence as a result of macroeconomic uncertainty. Temp & Contracting activity continues to be more resilient.

We currently expect Group like-for-like net fees to decline by 9% YoY in Q4 (8% on a working day adjusted basis) against a soft prior-year comparative, with Perm and Temp & Contracting down 14% and 5% respectively.

Our current cost base on a periodic and constant currency basis has improved to c.£75m from c.£76m in Q3. However, given the largely fixed short-term nature of our cost base there has been a high drop-through of lower net fees to profitability and, as a result, we currently expect FY25 pre-exceptional operating profit of c.£45m*

At a regional level, we expect like-for-like net fees in our largest country Germany to decrease by 5% with continued stability in Contracting but weaker conditions in Perm and Temp, primarily due to a subdued Automotive sector. Perm has also weakened in the UK&I and we expect a 13% divisional net fee decline, and similarly in ANZ where net fees are expected to be down 9% YoY.

Net fees are expected to decline by 9% YoY in RoW. EMEA ex-Germany (net fees down 13%) has experienced challenging Perm markets, particularly in France. Asia (net fees down 3%) is stable overall. Americas (net fees down 1%) with 5% YoY growth in North America where markets remain stable.

Cash performance remains in line with normal trends and we expect a modest net cash position at year-end.

We expect current challenging market conditions to persist into FY26 and remain committed to delivering our focused strategy. Our initiatives to improve net fee productivity in real terms and back-office efficiency will be important drivers of medium-term profit recovery when the market recovers.

* Company compiled consensus pre-exceptional operating profit for FY25 is £56.4m, based on ten analysts.

This announcement contains inside information. The person responsible for releasing this announcement is Rachel Ford, General Counsel & Company Secretary.

Conference call

James Hilton and Kean Marden will conduct a conference call for analysts and investors at 9:00am United Kingdom time on 19th June 2025. Participants are invited to register via the URL link below:

https://register-conf.media-server.com/register/BI3505905c97704359b604cfaecfe9ae42

Once registered, you will receive a confirmation email, with the details of the call and a personal login link and PIN which will place you directly into the call, without the need to speak to an operator. The call will be recorded and will also be available for playback via the results centre on our investor website.

Hays Plc Reporting calendar

Preliminary results for the year ending 30 June 202521 August 2025
Trading update for the quarter ending 30 September 2025 (Q1 FY26)10 October 2025
Trading update for the quarter ending 31 December 2025 (Q2 FY26)14 January 2026
Share on:
Find more news, interviews, share price & company profile here for:

    EDX Medical reports 2025 results and advances in cancer diagnostics

    EDX Medical Group has published its Annual Report for the year ending 31 March 2025, highlighting the development of a new AI-driven prostate cancer test, a £3 million fundraising, expanded European partnerships, and a service agreement with Royal Marsden NHS Foundation Trust.

    Diverse Income Trust reports £257.9m net assets with 4.18% yield

    Diverse Income Trust reported net assets of £257.9 million as of 31 July 2025, with a NAV of 109.08p per share and a share price of 104.00p, reflecting a 4.66% discount. The trust, managed by Gervais Williams and Martin Turner, delivered a 19.42% one-year share price total return and maintains a historic yield of 4.18%.

    Aptamer advances enzyme modulation projects and expands pharma collaboration

    Aptamer Group announced progress on its Optimer® enzyme modulation projects, including a 10-year non-exclusive licensing deal forecast to cover around 15% of annual overheads and further agreements under discussion with global enzyme distributors.

    Structured products fund Volta Finance reports July NAV of €274.2m, performance up 2.5%

    Volta Finance has reported a July net performance of +2.48%, including a dividend of 15.5 cents per share, bringing financial year gains to +13.9%. Net Asset Value stood at €274.2m (€7.49 per share), with strong contributions from CLO equity tranches, which returned +5.2% during the month

    12.2% total return in H1 2025! Global equity income trust GOT delivers

    Global Opportunities Trust reports a 4.0% NAV total return and a 12.2% share price total return for the six months to 30 June 2025, with net assets rising to £110.7 million.

    SAE Renewables rebrands as Ampeak Energy Limited

    Following shareholder approval at its AGM, SAE Renewables (SIMEC Atlantis) has formally changed its name to Ampeak Energy Limited. The move reflects the company’s transition as it advances its flagship AW1 battery storage project, one of the UK’s largest.

      Search

      Search